4//SEC Filing
MCCORMICK FRANK 4
Accession 0000950170-25-090498
CIK 0001743881other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 5:08 PM ET
Size
5.8 KB
Accession
0000950170-25-090498
Insider Transaction Report
Form 4
MCCORMICK FRANK
Director
Transactions
- Sale
Common Stock
2025-06-24$44.23/sh−100,000$4,422,800→ 879,979 total(indirect: By Trust)
Holdings
- 83,275
Common Stock
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 28, 2024.
- [F2]Represents the weighted average sale price of the shares sold from $44.00 to $44.69 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001257809
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 5:08 PM ET
- Size
- 5.8 KB